Similar Articles
541 Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients
542 Artificial neural network for prediction of acute kidney injury after liver transplantation for cirrhosis and hepatocellular carcinoma
543 Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long?
544 Long-term survival outcome of laparoscopic liver resection for hepatocellular carcinoma
545 Research progress regarding programmed cell death 1/programmed cell death ligand 1 inhibitors combined with targeted therapy for treating hepatocellular carcinoma
546 Outcomes of reduction hepatectomy combined with postoperative multidisciplinary therapy for advanced hepatocellular carcinoma
547 Single dose dexamethasone prophylaxis of postembolisation syndrome after chemoembolisation in hepatocellular carcinoma patient: A randomised, double-blind, placebo-controlled study
548 Thermal ablation and immunotherapy for hepatocellular carcinoma: Recent advances and future directions
549 Surveillance for hepatocellular carcinoma at the community level: Easier said than done
550 Extremely high titer of hepatitis B surface antigen antibodies in a primary hepatocellular carcinoma patient: A case report
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA